Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Bausch Health Companies Inc (BHC)

Bausch Health Companies Inc (BHC)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,458,284
  • Shares Outstanding, K 360,990
  • Annual Sales, $ 8,434 M
  • Annual Income, $ -948,000 K
  • 60-Month Beta 1.62
  • Price/Sales 0.40
  • Price/Cash Flow 1.04
  • Price/Book N/A
Trade BHC with:

Options Overview Details

View History
  • Implied Volatility 90.67% ( +11.81%)
  • Historical Volatility 119.68%
  • IV Percentile 98%
  • IV Rank 74.85%
  • IV High 110.72% on 05/11/22
  • IV Low 30.99% on 09/03/21
  • Put/Call Vol Ratio 0.90
  • Today's Volume 2,994
  • Volume Avg (30-Day) 16,126
  • Put/Call OI Ratio 0.52
  • Today's Open Interest 396,420
  • Open Int (30-Day) 466,691

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/22
See More
  • Average Estimate 0.97
  • Number of Estimates 4
  • High Estimate 1.11
  • Low Estimate 0.76
  • Prior Year 0.98
  • Growth Rate Est. (year over year) -1.02%

Price Performance

See More
Period Period Low Period High Performance
1-Month
7.80 +26.41%
on 05/10/22
21.44 -54.01%
on 04/28/22
-10.69 (-52.02%)
since 04/26/22
3-Month
7.80 +26.41%
on 05/10/22
24.38 -59.56%
on 02/28/22
-14.49 (-59.51%)
since 02/25/22
52-Week
7.80 +26.41%
on 05/10/22
32.54 -69.70%
on 06/01/21
-22.10 (-69.15%)
since 05/26/21

Most Recent Stories

More News
New Strong Sell Stocks for May 19th

ASX, CNMD, and BHC have been added to the Zacks Rank #5 (Strong Sell) List on May 19, 2022.

CNMD : 115.60 (+3.21%)
ASX : 6.93 (+2.97%)
BHC : 9.86 (+2.92%)
3 Pharmaceutical Stocks Under $11 to Buy Now

The global pharmaceutical market might cross the $1.5 trillion threshold by 2023, while national health spending is expected to increase over the coming years. And growing investments in breakthrough developments...

BHC : 9.86 (+2.92%)
CPRX : 7.02 (+2.03%)
PROC : 7.90 (+1.67%)
Why Bausch Health Is Down More Than 24% Today

The company shocked investors with its loss, although today may also be a major capitulation for the stock.

BHC : 9.86 (+2.92%)
BLCO : 18.00 (+5.94%)
Bausch (BHC) Q1 Earnings and Revenues Miss, Stock Down

Bausch (BHC) misses on earnings and sales in the first quarter due to incremental macro pressures and a challenging supply chain environment.

ALKS : 29.36 (+1.77%)
SRPT : 70.90 (+3.52%)
ABEO : 0.1541 (+0.52%)
BHC : 9.86 (+2.92%)
Scoop Up These 4 Buy-Rated Healthcare Stocks Trading Near 52-Week Lows

Despite the prevailing bearish investor sentiment, the healthcare industry is expected to continue growing amid an increase in global chronic diseases, rapid medical advancements, and an aging population....

ABCM : 14.54 (+1.96%)
BHC : 9.86 (+2.92%)
IART : 61.36 (+2.18%)
TFX : 285.47 (+0.87%)
Drug/Biotech Stocks' Q1 Earnings on May 10: EXEL, BHC & More

Let's look at the five biotech/drug companies that are slated to release quarterly results on May 10.

EXEL : 18.19 (+2.13%)
CPRX : 7.02 (+2.03%)
EPZM : 0.4394 (-9.16%)
RETA : 27.80 (+3.42%)
BHC : 9.86 (+2.92%)
BridgeBio Pharma (BBIO) Reports Q1 Loss, Misses Revenue Estimates

BridgeBio Pharma (BBIO) delivered earnings and revenue surprises of -5.31% and 80.59%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

BBIO : 6.62 (-0.15%)
BHC : 9.86 (+2.92%)
5 Undervalued Stocks to Scoop Up in May

The market selloff caused by the difficult macroeconomic and geopolitical issues has led many quality stocks to now trade below their intrinsic values. Agilent Technologies (A), United Therapeutics (UTHR),...

A : 123.85 (+2.88%)
BHC : 9.86 (+2.92%)
NSANY : 7.7900 (+1.17%)
UTHR : 224.78 (-1.58%)
WIRE : 123.87 (+3.29%)
Bausch Health (BHC) Stock Sinks As Market Gains: What You Should Know

Bausch Health (BHC) closed the most recent trading day at $18.85, moving -0.84% from the previous trading session.

BHC : 9.86 (+2.92%)
3 Generic Drug Stocks to Watch Amid Continued Pricing Pressure

The impact of COVID-19 and continued pricing pressure on the Zacks Medical-Generic Drugs industry remains. New product launches may provide some respite for BHC, AMPH and SLGL.

BHC : 9.86 (+2.92%)
AMPH : 36.18 (-1.47%)
SLGL : 5.94 (+1.19%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Bausch Health Companies Inc. develops and distributes drugs. It develops drugs for unmet medical needs in central nervous system disorders and distributes generic and branded generic drugs primarily in Latin America and Eastern Europe. Bausch Health Companies Inc., formerly known as Valeant Pharmaceuticals,...

See More

Key Turning Points

3rd Resistance Point 10.74
2nd Resistance Point 10.33
1st Resistance Point 10.10
Last Price 9.86
1st Support Level 9.46
2nd Support Level 9.05
3rd Support Level 8.82

See More

52-Week High 32.54
Fibonacci 61.8% 23.09
Fibonacci 50% 20.17
Fibonacci 38.2% 17.25
Last Price 9.86
52-Week Low 7.80

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar